- Home
- DDS vs QGEN Comparison
DDS vs QGEN Comparison
Compare DDS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDS | QGEN |
|---|---|---|
| Founded | 1938 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | DDS | QGEN |
|---|---|---|
| Price | $691.99 | $45.07 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $511.33 | $49.74 |
| AVG Volume (30 Days) | 131.1K | ★ 1.2M |
| Earning Date | 11-13-2025 | 02-04-2026 |
| Dividend Yield | ★ 4.58% | 3.34% |
| EPS Growth | N/A | ★ 331.20 |
| EPS | ★ 36.93 | 1.84 |
| Revenue | ★ $6,625,563,000.00 | $2,070,781,000.00 |
| Revenue This Year | $0.60 | $7.12 |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | ★ $18.46 | $24.59 |
| Revenue Growth | N/A | ★ 5.32 |
| 52 Week Low | $282.24 | $37.63 |
| 52 Week High | $741.98 | $51.88 |
Technical Indicators
Market Signals| Indicator | DDS | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 41.49 |
| Support Level | $680.93 | $44.82 |
| Resistance Level | $741.98 | $47.48 |
| Average True Range (ATR) | 25.84 | 0.60 |
| MACD | 1.63 | -0.19 |
| Stochastic Oscillator | 57.75 | 9.04 |
Price Performance
Historical ComparisonAbout DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).